Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The qualification period.

P Knipschild1, P Leffers, A R Feinstein

  • 1Department of Epidemiology/Health Care Research, Rijksuniversiteit Limburg, Maastricht, The Netherlands.

Journal of Clinical Epidemiology
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

THE PRE-THERAPEUTIC CLASSIFICATION OF CO-MORBIDITY IN CHRONIC DISEASE.

Journal of chronic diseases·2015
Same author

NATURAL HISTORY AND TREATMENT OF RHEUMATIC FEVER.

A listing of research in the cardiovascular field·2014
Same author

Mistletoe treatment for cancer review of controlled trials in humans.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2012
Same author

II. Treatment and Prevention.

The Yale journal of biology and medicine·2011
Same author

The need for clinical trials registers: a case study in the field of addiction.

Addiction (Abingdon, England)·2005
Same author

Do drug firms hoodwink medical journals? Or is something wrong with the contribution and integrity of declared authors?

Journal of medical ethics·2005
Same journal

A comparison of five statistical methods used to analyse longitudinal EORTC QLQ-C30 quality of life scores in randomised controlled trials: a simulation study.

Journal of clinical epidemiology·2026
Same journal

Sample Size Determination for Decision-centered Pragmatic Trials.

Journal of clinical epidemiology·2026
Same journal

Many multicenter randomized controlled trials do not account for center effect: a methodological review.

Journal of clinical epidemiology·2026
Same journal

Patient Acceptability of the Modified Zelen Approach to Randomized Trials - A Survey of the CAPS THA Cohort.

Journal of clinical epidemiology·2026
Same journal

Corrigendum to SPICE-GRADE: simultaneous processing of indirect causal evidence in complex pathways using GRADE - an exploratory case study. [Journal of Clinical Epidemiology, 194C (2026) 112219].

Journal of clinical epidemiology·2026
Same journal

Small numbers of clusters in cluster randomised trials: a scoping review of problems and proposed solutions.

Journal of clinical epidemiology·2026
See all related articles

The qualification period in clinical trials helps manage patient eligibility and treatment adjustments before randomization. This pre-admission phase improves trial design, data analysis, and ethical considerations for better research outcomes.

Area of Science:

  • Clinical Trials Methodology
  • Medical Research Design
  • Pharmaceutical Research

Background:

  • Randomized controlled trials (RCTs) often face challenges in patient selection, treatment adherence, and data integrity.
  • Pre-randomization phases can address these issues, but their full potential is not always realized.

Purpose of the Study:

  • To highlight the utility of a "qualification period" as a pre-admission phase in RCTs.
  • To demonstrate how this period can resolve common design, analysis, and ethical challenges.

Main Methods:

  • The qualification period allows for washout of prior treatments and verification of eligibility criteria.
  • It enables identification of prognostic indicators and stratification of patient subgroups.
  • Therapeutic dosages can be tested, placebo responders excluded, and early treatment response confirmed.

Related Experiment Videos

Main Results:

  • The qualification period facilitates intention-to-treat analyses by allowing stratification for patients with compliance or regulation issues.
  • It provides a "pilot exposure" to enhance informed consent and ethical conduct.
  • This phase improves the overall quality and feasibility of RCTs.

Conclusions:

  • Implementing a qualification period in RCTs offers significant advantages for patient management and data quality.
  • It enhances the scientific rigor and ethical integrity of clinical research.
  • This structured pre-randomization approach is valuable for trials not requiring immediate therapeutic intervention.